Skip to main content
  • Sign in
  • Help
BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2025
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Specialist Advisory Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2025
    • Abstract Submission Opens 31st March
    • Past Symposiums / Conferences
  • News & Events
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Join BOPA
Join BOPA
BOPA Join BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2025
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Specialist Advisory Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2025
    • Abstract Submission Opens 31st March
    • Past Symposiums / Conferences
  • News & Events
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Join BOPA

Home » 2023

2023

BOPA encourages its members to share helpful documents that can benefit other members.  BOPA respects the intellectual property of original authors and requires anyone who uses other members’ work to include an acknowledgment of, or reference to, the source in their version.

DISCLAIMER:
BOPA is not the author or owner of some of the documents published on our website.  BOPA as a professional interest group will share documents via its website that are of interest to BOPA members, but has no responsibility for use of the documents and for any recommendations within the documents so members must use these at their discretion. BOPA cannot accept responsibility for any errors or omissions or for any consequences from application of information in the documents attached and make no warranty, expressed or implicit with respect to the contents of this webpage. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site or document(s) downloaded from it.

Posters and abstracts on the BOPA website remain the property of the authors and anyone wishing to reference or share this work must contact the authors directly. Abstracts subsequently published in JOPP follow copyright rules from JOPP.

Last reviewed: 15/11/23 by Riona Browne

Evaluating the Incidence and Management of Hypertension with Compassionate Use Lenvatinib in Endometrial Cancer

Abstracts

View resources
Last reviewed: 15/11/23 by Bastiaan Buijtenhuijs

Patient BMI as an Indicator of Height and Weight Input Errors

Abstracts

View resources
Last reviewed: 15/11/23 by Suyee Chan

An Audit on the Use of Rasburicase and Management of Tumour Lysis Syndrome in Adult Patients with Haematological Malignancies at Guy’s and St Thomas’ NHS Trust

Abstracts

View resources
Last reviewed: 15/11/23 by Tiffany Chan

An Audit on the Outcome of Patients Treated with Trifluridine-Tipiracil (TAS-102) for Metastatic Colorectal Cancer in a Real World Setting

Abstracts

View resources
Last reviewed: 15/11/23 by Cheuk-kie Jackie Cheung

Long-Term Blood Monitoring for Ribociclib: Real Life Data at a Tertiary Cancer Centre

Abstracts

View resources
Last reviewed: 15/11/23 by Gerard Gurumurthy

Incidence and Management of Acute Oxaliplatin Neurological Toxicity Including Laryngospasm in Colorectal Cancer Patients at the Christie Hospital

Abstracts

View resources
Last reviewed: 15/11/23 by Sarah E. Craig

A Retrospective Review of Prostate Cancer Patients Commenced on Novel Hormonal Therapies Concurrently Receiving Anticoagulation Therapy Over a 12-Month Period

Abstracts

View resources
Last reviewed: 15/11/23 by Sarah E. Craig

Retrospective Review of Renal Function in Sarcoma Patients Receiving Ifosfamide. Evaluating the Suitability of C&G and Wright Renal Estimation Formulas

Abstracts

View resources
Last reviewed: 15/11/23 by Sarah E. Craig

Wright vs Cockcroft and Gault (C&G): A Comparison of Two Formulas Used to Estimate Renal Function in Chemotherapy Patients Across Two Hubs in a specialist cancer centre.

Abstracts

View resources
Last reviewed: 15/11/23 by Rebecca Devine

Real-World Data for the Use of Triplet Therapy in Metastatic, Hormone-Sensitive Prostate Cancer: Darolutamide Plus Docetaxel and ADT

Abstracts

View resources
Last reviewed: 15/11/23 by Milly Finch

Dihydropyrimidine Dehydrogenase (DPYD) Clinical Audit in Cancer Patients

Abstracts

View resources
Last reviewed: 15/11/23 by Malcolm Odita

Prophylactic Antibiotics and G-CSF Prescribing in Adults with Sarcoma Receiving Systemic Anti-Cancer Therapy (SACT) at Risk of Febrile Neutropenia (FN) – a Re-Audit

Abstracts

View resources

Filter for resources

  • Types

  • Tags

  • Reset

Previous 1 2 3 … 19 Next
BOPA logo
  • Why join BOPA
  • Pricing/Join
  • Conference 2024
  • Education
  • About
  • News & Events
  • Help
  • Go to LinkedIn
  • Go to Twitter
  • Go to Facebook
  • Go to Instagram
  • Go to Bluesky

© Copyright 2025 British Oncology Pharmacy Association.
Registered Charity No. 1065026

  • Privacy Policy
  • T&Cs Website
  • T&Cs Membership
  • Cookies
  • Contact
Designed and developed by Rouge
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.